[ad_1]
WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patients
Start: 16 Oct 2020 09:20 GMT
End: 16 Oct 2020 12:00 GMT
GENEVA, SWITZERLAND – WHO spokesman Tarik Jašarević reads statement on Gilead Sciences Inc’s remdesivir having little or no effect on COVID-19 patients’ length of hospital stay or chances of survival, according to a clinical trial by the World Health Organization (WHO).
Restrictions:
BROADCAST: NONE
DIGITAL: NONE
Source: REUTERS
Aspect Ratio: 16:9
Location: Switzerland
Topic: Science / Technology
Audio: NATURAL / ENGLISH
Editorial Support: +44 20 7542 2244
Email: [email protected]
[ad_2]
Source link